Works matching AU Abadi, Uri


Results: 15
    1
    2
    3
    4

    P651: REAL‐WORLD EFFECTIVENESS OF VENETOCLAX‐BASED REGIMENS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN ISRAEL: UPDATE FROM THE MULTICENTER PROSPECTIVE REVEAL STUDY.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000969508.44280.24
    By:
    • Herishanu, Yair;
    • Goldschmidt, Neta;
    • Itchaki, Gilad;
    • Bronstein, Yotam;
    • Levi, Itai;
    • Aviv, Ariel;
    • Fineman, Riva;
    • Dally, Najib;
    • Tadmor, Tamar;
    • Ronson, Aaron;
    • Abadi, Uri;
    • Shvidel, Levi;
    • Stemer, Galia;
    • Kay, Sigi;
    • Glait Santar, Chen;
    • Barak, Moran;
    • Rivlin, Noa;
    • Kaminsky, Natalie;
    • Cohen, Raanan;
    • Ofek, Keren
    Publication type:
    Article
    5

    Outcome of relapsed/refractory diffuse large B-cell lymphoma patients treated with polatuzumab vedotin-based therapy: real-life experience.

    Published in:
    Leukemia & Lymphoma, 2021, v. 62, n. 1, p. 118, doi. 10.1080/10428194.2020.1824069
    By:
    • Segman, Yafit;
    • Ribakovsky, Elena;
    • Avigdor, Abraham;
    • Goldhecht, Yair;
    • Vainstein, Vladimir;
    • Goldschmidt, Neta;
    • Harlev, Shimrit;
    • Horwitz, Netanel;
    • Gutwein, Odit;
    • Gurion, Ronit;
    • Itchaki, Gilad;
    • Abadi, Uri;
    • Nemets, Anatoly;
    • Sofer, Orit;
    • Zektser, Miri;
    • Tadmor, Tamar;
    • Dally, Nagib;
    • Filanovsky, Kalman;
    • Leiba, Merav;
    • Sarid, Nadav
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12

    Modification of initial therapy in early and advanced Hodgkin lymphoma, based on interim PET/ CT is beneficial: a prospective multicentre trial of 355 patients.

    Published in:
    British Journal of Haematology, 2017, v. 178, n. 5, p. 709, doi. 10.1111/bjh.14734
    By:
    • Dann, Eldad J.;
    • Bairey, Osnat;
    • Bar‐Shalom, Rachel;
    • Mashiach, Tanya;
    • Barzilai, Elinor;
    • Kornberg, Abraham;
    • Akria, Luiza;
    • Tadmor, Tamar;
    • Filanovsky, Kalman;
    • Abadi, Uri;
    • Kagna, Olga;
    • Ruchlemer, Rosa;
    • Abdah‐Bortnyak, Roxolyana;
    • Goldschmidt, Neta;
    • Epelbaum, Ron;
    • Horowitz, Netanel A.;
    • Lavie, David;
    • Ben‐Yehuda, Dina;
    • Shpilberg, Ofer;
    • Paltiel, Ora
    Publication type:
    Article
    13

    ABCL-366: Mosunetuzumab (Mosun) Monotherapy for Elderly/Unfit Patients with First-Line Diffuse Large B-Cell Lymphoma (DLBCL) Continues to Show Promising Safety and Efficacy with Durable Complete Responses.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S395, doi. 10.1016/S2152-2650(21)01896-6
    By:
    • Olszewski, Adam;
    • Avigdor, Abraham;
    • Babu, Sunil;
    • Levi, Itai;
    • Eradat, Herbert;
    • Abadi, Uri;
    • Holmes, Houston;
    • McKinney, Matthew;
    • Woszczyk, Dariusz;
    • Giannopoulos, Krzysztof;
    • Jurczak, Wojciech;
    • McCord, Ron;
    • Yuying Xie;
    • Mingzhu Zhou;
    • Qayum, Naseer;
    • O'Hear, Carol;
    • Sellam, Gila;
    • Horowitz, Netanel
    Publication type:
    Article
    14

    Poster: ABCL-366: Mosunetuzumab (Mosun) Monotherapy for Elderly/Unfit Patients with First-Line Diffuse Large B-Cell Lymphoma (DLBCL) Continues to Show Promising Safety and Efficacy with Durable Complete Responses.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S239, doi. 10.1016/S2152-2650(21)01501-9
    By:
    • Olszewski, Adam;
    • Avigdor, Abraham;
    • Babu, Sunil;
    • Levi, Itai;
    • Eradat, Herbert;
    • Abadi, Uri;
    • Holmes, Houston;
    • McKinney, Matthew;
    • Woszczyk, Dariusz;
    • Giannopoulos, Krzysztof;
    • Jurczak, Wojciech;
    • McCord, Ron;
    • Yuying Xie;
    • Mingzhu Zhou;
    • Qayum, Naseer;
    • O'Hear, Carol;
    • Sellam, Gila;
    • Horowitz, Netanel
    Publication type:
    Article
    15